Skip to main content

Advertisement

Log in

Effectiveness of ketogenic diet in treatment of patients with refractory chronic migraine

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background and purpose

Ketogenic diet (KD) is based on restriction of carbohydrate intake. Metabolism is forced to obtain energy starting from β-oxidation of fatty acids which, turned into ketone bodies, can also be used by central nervous system (CNS). KD use in treatment of chronic migraine has recently been considered. We set out to verify modification of symptoms in patients with refractory chronic migraine in response to KD.

Methods

Fifty patients were enrolled of which 38 completed the procedures the study and 23 were considered in the statistics. All of the patients considered in our study were affected by medication overuse headache (MOH). They were on a KD for 3 months. The following parameters have been checked at t = 0 and every 30 days for 6 months: migraine episode length (n. hours/day), frequency (n. days/month), level of pain of every episode measured on a scale from 1 to 3 (1 = mild; 2 = moderate; 3 = severe), and n. analgesic drugs taken/month.

Results

Days with symptoms decreased from 30 (median value) to 7.5 with p < 0.0001. The duration of the migraine episodes decreased from 24 h (median value) to 5.5 h with p < 0.0016. The patients’ pain level, initially at maximum value for 83% of the participants, improved for 55% of them (p < 0.0024). The number of drugs taken in a month decreased from 30 doses (median value) to 6 doses.

Conclusions

It can be stated that a 3-month KD resulted in a reduction of painful symptoms of drug refractory chronic migraine. This result may suggest an improvement in quality of life of the patients, even without a tabulated data collection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38(1):1–211

    Article  Google Scholar 

  2. Schulman EA, Lake AE 3rd, Goadsby PJ, Peterlin BL, Siegel SE, Markley HG, Lipton RB (2008) Defining refractory migraine and refractory chronic migraine: proposed criteria from the refractory headache special interest section of the American headache society. Headache. 48:778–782

    Article  Google Scholar 

  3. Lionetto L., Negro A., Palmisani S., Gentile G., Del Fiore M.R., Mercieri M., Simmaco M., Smith T., Al-Kaisy A., Arcioni R., Martelletti P. Emerging treatment for chronic migraine and refractory chronic migraine. Expert Opin Emerg Drugs. 2012 Sep;17(3):393–406 2012 Aug 3

  4. Paoli A, Bianco A, Damiani E, Bosco G (2014) Ketogenic diet in neuromuscular and neurodegenerative diseases. Biomed Res Int 2014:474296

    Article  Google Scholar 

  5. Stafstrom CE, Rho JM (2012) The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol 9:3–59

    Google Scholar 

  6. Puchalska P. and Crawford P.A. A Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab. 2017; 7; 25(2):262–284

  7. Veyrat-Durebex C. et al. Review: how can a ketogenic diet improve motor function? Front Mol Neurosci. 2018 Feb; Jan 26; 11:15

  8. Martin-McGill KJ, Jackson CF, Bresnahan R et al (2018 Nov) Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev 7:11

    Google Scholar 

  9. Di Lorenzo C et al (2015 Jan) Migraine improvement during short lasting ketogenesis: a proof-of-concept study. Eur J Neurol 22(1):170–177

    Article  Google Scholar 

  10. Di Lorenzo C, Coppola G, Di Lenola D, Evangelista M, Sirianni G, Rossi P, Di Lorenzo G, Serrao M, Pierelli F (2018 Feb 12) Efficacy of modified Atkins ketogenic diet in chronic cluster headache: an open-label, single arm, clinical trial. Front Neurol 9:64

    Article  Google Scholar 

  11. Barbanti et al., Ketogenic diet in migraine: Rationale, findings and perspective. Neurological Sciences. 2017 May; 38(Suppl 1):111–115

  12. Tepper SJ (2012 Aug) Medication-overuse headache. Continuum. 18(4):807–822

    PubMed  Google Scholar 

  13. Westergaard M.L. el al. Medication-overuse headache: A perspective review. Therapeutic Advances in Drug Safety. 2016 Aug; 7(4):147–158

  14. EFSA (European Food Safety Authority) Journal 2015: scientific opinion on the essential composition of total diet replacements for weight control

  15. Tanya J. W. Mc Donald and Mackenzie C. Cervenka. The expanding role of ketogenic diets in adult neurological disorders. Review. Brain Sciences. 2018 Aug 8;8(8)

  16. Cai QY, Zhou ZJ, Luo R, Gan J, Li SP, Mu DZ, Wan CM (2017 Dec) Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies. World J Pediatr 13(6):528–536

    Article  Google Scholar 

  17. Cervenka M.C., Hocker S. et al. Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticus. Neurology. Mar 7;88(10):938–943

  18. Colica C, Merra G, Gasbarrini A, de Lorenzo A, Cioccoloni G, Gualtieri P, Perrone MA, Bernardini S, Bernardo V, di Renzo L, Marchetti M (2017 May) Efficacy and safety of very-low-calorie ketogenic diet: a double-blind randomized crossover study. Eur Rev Med Pharmacol Sci 21(9):2274–2289

    CAS  PubMed  Google Scholar 

  19. Gershuni VM, Yan SL, Medici V (2018 Sep) Nutritional ketosis for weight management and reversal of metabolic syndrome. Review Current Nutrition Reports 7(3):97–106

    Article  CAS  Google Scholar 

  20. Leslie WS, Taylor R, Harris L, Lean MEJ (2017 Jun) Weight losses with low-energy formula diets in obese patients with and without type 2 diabetes: systematic review and meta-analysis. Int J Obes 41(6):997

    Article  CAS  Google Scholar 

  21. Cicero Arrigo FG et al (2015 Dec) Middle and long-term impact of a very low-carbohydrate ketogenic diet on cardiometabolic factors: a multi-center, cross-sectional, clinical study. High Blood Pressure and Cardiovascular Prevention 22(4):389–394

    Article  CAS  Google Scholar 

  22. Newman JC, Verdin E (2014 Nov) B-hydroxybutyrate: much more than a metabolite. Diabetes Res Clin Pract 106(2):173–181

    Article  CAS  Google Scholar 

  23. Di Lorenzo C et al (2016) Cortical functional correlates of responsiveness to short lasting preventive intervention with ketogenic diet in migraine: a multimodal evoked potentials study. The Journal of Headache and Pain 17:58

    Article  Google Scholar 

  24. Trucco M, Meineri P, Ruizon L (2005) Behalf of the “Gruppo Neurologico Ospedaliero Interregionale per lo studio delle Cefalee” (neurological hospital interregional group for the study of headaches). Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache. J Headache Pain 6:334–337

    Article  Google Scholar 

  25. Paolucci M, Altamura C, Brunelli N, Cascio RA, Assenza F, Pasqualetti P, Vernieri F (2017) Methylprednisolone plus diazepam i.v. as bridge therapy for medication overuse headache. Neurol Sci 38:2025–2029

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

DB and CDF performed study design, collected the data, performed data analysis, and wrote the manuscript. FO, SC, and GBA performed study design, collected the data, and collaborated to data analysis and manuscript writing. MF performed data analysis. CB and SS revised the manuscript critically for important intellectual content. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Maurizio Fadda.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

Study protocol was approved by our local ethics committee at the City of Health and Science, Turin, Italy (27/02/2019 protocol no. 022551, file no. CS2/1006). This observational study was based solely on information and investigations that were carried out as part of the routine clinical care of the patients. This article was written in accordance with the requirements of the Declaration of Helsinki (2001).

Informed consent

Informed consent was obtained from adult patients.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bongiovanni, D., Benedetto, C., Corvisieri, S. et al. Effectiveness of ketogenic diet in treatment of patients with refractory chronic migraine. Neurol Sci 42, 3865–3870 (2021). https://doi.org/10.1007/s10072-021-05078-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-021-05078-5

Keywords

Navigation